Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antithrombin Supplementation in VV-ECMO
NCT03208270Phase 3Completed
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Jul 2017
- Primary completion
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antithrombin III in respiratory failure, sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Started Jul 2017; status: completed.
02
Drugs
antithrombin III
03
Conditions
respiratory failure
Beyond the preview
Go deeper on NCT03208270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03208270.